Quide vs. Mellaril in chronic schizophrenic patients.
D000284:Administration, Oral; D000328:Adult; D001519:Behavior / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005260:Female; D006212:Hallucinations / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007659:Ketones / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage* / Q000009:adverse effects; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000008:administration & dosage* / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects
D007659:Ketones; D010640:Phenothiazines; D010879:Piperazines; D014149:Tranquilizing Agents; D013881:Thioridazine